Literature DB >> 10096726

Towards the safer use of non-steroidal anti-inflammatory drugs.

R O Day1, D Rowett, E E Roughead.   

Abstract

Musculoskeletal conditions afflict most of us at some time in our lives, and we all have relatives and friends who suffer the pain and disability sometimes associated with conditions such as back or neck pain, fibrositis and osteoarthritis. The goal of those of us who try to help individuals with these conditions is to achieve effective, but also safe, management of their musculoskeletal disorders, the commonest symptom of which is pain. This goal can be achieved by better diagnosis and problem formulation (allowing better selection of treatment options); informed selection of non-drug and drug therapeutic options, based on relative cost-benefit considerations; and the judicious, appropriate and safe use of drugs, particularly non-steroidal anti-inflammatory drugs (NSAID). Setting realistic goals and maintaining regular surveillance of patients are also important considerations. Finally, the active involvement of the patient in their own management is associated with better and safer outcomes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10096726     DOI: 10.1046/j.1440-1762.1999.00287.x

Source DB:  PubMed          Journal:  J Qual Clin Pract        ISSN: 1320-5455


  3 in total

1.  Comparison of high-intensity laser therapy and combination of ultrasound treatment and transcutaneous nerve stimulation in patients with cervical spondylosis: a randomized controlled trial.

Authors:  M Venosa; E Romanini; R Padua; S Cerciello
Journal:  Lasers Med Sci       Date:  2018-11-15       Impact factor: 3.161

2.  Effectiveness of percutaneous neuromuscular electrical stimulation for neck pain relief in patients with cervical spondylosis.

Authors:  Qiang Miao; Jian-Hong Qiang; Yan-Li Jin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  Electroacupuncture at Jing-jiaji points for neck pain caused by cervical spondylosis: a study protocol for a randomized controlled pilot trial.

Authors:  Zhong-ren Sun; Jin-huan Yue; Qin-hong Zhang
Journal:  Trials       Date:  2013-10-29       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.